multiple t-cell epitopes of hiv-1 nef containing positively selected mutations associated with...

1
compared to progressing (34.9%) individuals (P < 0.001, OR = 0.17). Conclusions: The E3K SNP is likely to affect both CXCR6 cell surface expression and/or binding of its ligand. Thus, we hy- pothesize that the high prevalence and interplay of both these mutations in Black South African individuals may be masking the effect of the rs2234358 SNP on LTNP within this population. P37.07 Cytokines Genes Polymorphisms in Ukrainian HIV-1 Infected Individuals Anna Ivanivna Piddubna 1 Sumy State University, Infectious Diseases and Epidemiology Department, Sumy, Ukraine Background: The objective of the research was to study dis- tribution character of the allelic variants of cytokines genes in HIV-1 infected Ukrainians. Methods: Data for the study were DNA samples, received from 200 inhabitants of Ukraine: 78 HIV-infected, 22 - HIV-negative individuals from the group of high risk of contamination, 100 healthy blood donors. IL-4 (-590C/T), IL-10 (-592C/A) and TNF-a (-308G/A) genes polymorphisms detection was made with PCR-RLFP method. Results: By analysis of frequency of IL-4 gene allelic variants it has been discovered that homozygotes by the main allel were the dominant variant. Among people with HIV T/T minor gene carriers were 4.5 more often met in comparison with control group (p < 0.05) that can prove the tendency to association of the mentioned genotype with infection. Distribution of allelic variants of IL-10 gene promoter region in position - 592 is characterized by homozygote dominance by the main gene. Among the individuals with HIV A/A minor allel carriers were 3.4 more often met in comparison with control group (p < 0.05). Individuals with A/A genotype were not identified in group of high risk of virus infection. The above- mentioned proves the tendency to association of minor allel carrier state with HIV infection. The occurrence of the homozygous combination of the allelic variant G/G of the promoter of TNF-a has been shown to prevail almost twofold over the occurrence of the variant G/A among all groups. High frequency of heterozygote by the main allel has been recorded among the individuals with HIV. Thus, G/A ge- notype frequency in group of HIV-infected people 2 and 1.5 exceeded the appropriate indices of group of high risk of in- fection and comparison group correspondingly (p < 0.05) that points to the tendency to association of the mentioned variant with infection. Conclusions: Cytokines genes variations may contribute to the acquisition of HIV infection and encourages carrying out of further populations studies in this sphere of HIV-infection im- munogenetics. P37.08 Multiple T-cell Epitopes of HIV-1 Nef Containing Positively Selected Mutations Associated with Different Disease Outcome Elnaz Shadabi 1 , Raghavan Sampathkumar 1 , John Ho 2 , David La 2 , Rupert Capina 2 , Binhu Liang 2 , Jeff Tuff 2 , Joshua Kimani 3 , T. Blake Ball 1,2 , Francis Plummer 1,2 , Ma Luo 1,2 1 University of Manitoba, Department of Medical Microbiology, Winnipeg, MB, Canada, 2 National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada, 3 University of Nairobi, Nairobi, Kenya Background: HIV-1 Nef plays a major role in enhancing the pathogenicity of the virus through various mechanisms such as down-regulation of CD4 and HLA class I surface expression and interfering with cell signaling pathways. Identifying and char- acterizing CD8 + T cell epitopes in Nef that are under host immune selection can help in selecting targets for an effective vaccine. Methods: 326 subtype A Nef sequences from treatment naı ¨ve patients of a Kenyan sex-worker cohort were generated using 454 pyrosequencing. Positively selected (PS) mutations were determined using a bioinformatics approach, quasi analysis. Peptides were designed with mutation placed in anchor position 2, 5, 8, 9 of epitopes of HLA class I alleles for validation with ELISpot assay using patient PBMCs. Results: E70D, I109V and I176M were associated with rapid CD4 decline ( p = 0.010, 0.015, 0.025 respectively). H124N and K190M were associated with slow CD4 decline ( p = 0.001 and 0.029). The five PS mutations were significantly associated with HLA class I alleles including A*23:01 (E70D, p = 0.002; I176M, p = 0.003), A*02:01 (I109V, p = 0.028; H124N, p = 0.021), B*58:01 (I109V, p = 0.048), A*3002, B*57:03 and C*02:01 (H124N, p = 0.026, 0.0004, and 0.011 respectively) and C*06:02 (K190M, p = 0.037). ELISpot analysis identified 27 novel epitopes containing either the consensus or the PS mutations. Six new epitopes contained E70D, five epitopes contained K190M, and I109V and H124N were each contained by eight new epitopes. No epitopes containing I176M was confirmed by ELISpot. It is pos- sible that I176M represents compensatory mutations due to functional requirements under host immune selective pressure. Conclusions: Identification and characterization of epitopes containing beneficial and detrimental PS mutations can provide important insight for selecting immunogens for an effective HIV vaccine. More detailed investigation of T-cell responses, such as poly-functionality and proliferation to these mutations will be conducted to further characterize these Nef epitopes. Innovations in Vaccine and Microbicides Studies in Lab and Monitoring P38.01 Operational Challenges for the Set-up of Gram Stain Analysis for Diagnosing Bacterial Vaginosis in a Local Laboratory in Durban, South Africa Natasha Gounden, Nathlee Abbai, Rashika Maharaj Medical Research Council, HIV Prevention Research Unit, Durban, South Africa Background: Studies have demonstrated the association between BV and HIV acquisition in woman. The prevalence of BV re- ported in clinical trials conducted by the Medical Research Council HIV Prevention Research Unit (MRC HPRU) is between 5–9%. In an attempt to reduce turnaround time for results, enable direct contact with research clinics, facilitate staff capacitation and reduce costs, the HPRU was selected by the Protocol Re- ference Laboratory to perform in-house testing for diagnosing BV. We report here on the operational challenges associated with the set-up of the laboratory to perform the analysis. A220

Upload: ma

Post on 27-Mar-2017

212 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Multiple T-cell Epitopes of HIV-1 Nef Containing Positively Selected Mutations Associated with Different Disease Outcome

compared to progressing (34.9%) individuals (P < 0.001,OR = 0.17).Conclusions: The E3K SNP is likely to affect both CXCR6 cellsurface expression and/or binding of its ligand. Thus, we hy-pothesize that the high prevalence and interplay of both thesemutations in Black South African individuals may be maskingthe effect of the rs2234358 SNP on LTNP within this population.

P37.07Cytokines Genes Polymorphisms in Ukrainian HIV-1Infected Individuals

Anna Ivanivna Piddubna

1Sumy State University, Infectious Diseases and EpidemiologyDepartment, Sumy, Ukraine

Background: The objective of the research was to study dis-tribution character of the allelic variants of cytokines genes inHIV-1 infected Ukrainians.Methods: Data for the study were DNA samples, received from200 inhabitants of Ukraine: 78 HIV-infected, 22 - HIV-negativeindividuals from the group of high risk of contamination, 100healthy blood donors. IL-4 (-590C/T), IL-10 (-592C/A) andTNF-a (-308G/A) genes polymorphisms detection was madewith PCR-RLFP method.Results: By analysis of frequency of IL-4 gene allelic variants ithas been discovered that homozygotes by the main allel were thedominant variant. Among people with HIV T/T minor genecarriers were 4.5 more often met in comparison with controlgroup (p < 0.05) that can prove the tendency to association of thementioned genotype with infection.Distribution of allelic variants of IL-10 gene promoter region inposition - 592 is characterized by homozygote dominance by themain gene. Among the individuals with HIV A/A minor allelcarriers were 3.4 more often met in comparison with controlgroup (p < 0.05). Individuals with A/A genotype were notidentified in group of high risk of virus infection. The above-mentioned proves the tendency to association of minor allelcarrier state with HIV infection.The occurrence of the homozygous combination of the allelicvariant G/G of the promoter of TNF-a has been shown to prevailalmost twofold over the occurrence of the variant G/A among allgroups. High frequency of heterozygote by the main allel hasbeen recorded among the individuals with HIV. Thus, G/A ge-notype frequency in group of HIV-infected people 2 and 1.5exceeded the appropriate indices of group of high risk of in-fection and comparison group correspondingly (p < 0.05) thatpoints to the tendency to association of the mentioned variantwith infection.Conclusions: Cytokines genes variations may contribute to theacquisition of HIV infection and encourages carrying out offurther populations studies in this sphere of HIV-infection im-munogenetics.

P37.08Multiple T-cell Epitopes of HIV-1 Nef ContainingPositively Selected Mutations Associated with DifferentDisease Outcome

Elnaz Shadabi1, Raghavan Sampathkumar1, John Ho2, DavidLa2, Rupert Capina2, Binhu Liang2, Jeff Tuff2, Joshua Kimani3,T. Blake Ball1,2, Francis Plummer1,2, Ma Luo1,2

1University of Manitoba, Department of Medical Microbiology,Winnipeg, MB, Canada, 2National Microbiology Laboratory,Public Health Agency of Canada, Winnipeg, MB, Canada,3University of Nairobi, Nairobi, Kenya

Background: HIV-1 Nef plays a major role in enhancing thepathogenicity of the virus through various mechanisms such asdown-regulation of CD4 and HLA class I surface expression andinterfering with cell signaling pathways. Identifying and char-acterizing CD8 + T cell epitopes in Nef that are under hostimmune selection can help in selecting targets for an effectivevaccine.Methods: 326 subtype A Nef sequences from treatment naı̈vepatients of a Kenyan sex-worker cohort were generated using454 pyrosequencing. Positively selected (PS) mutations weredetermined using a bioinformatics approach, quasi analysis.Peptides were designed with mutation placed in anchor position2, 5, 8, 9 of epitopes of HLA class I alleles for validation withELISpot assay using patient PBMCs.Results: E70D, I109V and I176M were associated with rapidCD4 decline ( p = 0.010, 0.015, 0.025 respectively). H124N andK190M were associated with slow CD4 decline ( p = 0.001 and0.029). The five PS mutations were significantly associated withHLA class I alleles including A*23:01 (E70D, p = 0.002; I176M,p = 0.003), A*02:01 (I109V, p = 0.028; H124N, p = 0.021),B*58:01 (I109V, p = 0.048), A*3002, B*57:03 and C*02:01(H124N, p = 0.026, 0.0004, and 0.011 respectively) and C*06:02(K190M, p = 0.037). ELISpot analysis identified 27 novel epitopescontaining either the consensus or the PS mutations. Six newepitopes contained E70D, five epitopes contained K190M, andI109V and H124N were each contained by eight new epitopes. Noepitopes containing I176M was confirmed by ELISpot. It is pos-sible that I176M represents compensatory mutations due tofunctional requirements under host immune selective pressure.Conclusions: Identification and characterization of epitopescontaining beneficial and detrimental PS mutations can provideimportant insight for selecting immunogens for an effective HIVvaccine. More detailed investigation of T-cell responses, such aspoly-functionality and proliferation to these mutations will beconducted to further characterize these Nef epitopes.

Innovations in Vaccine and Microbicides Studiesin Lab and Monitoring

P38.01Operational Challenges for the Set-up of Gram StainAnalysis for Diagnosing Bacterial Vaginosis in a LocalLaboratory in Durban, South Africa

Natasha Gounden, Nathlee Abbai, Rashika Maharaj

Medical Research Council, HIV Prevention Research Unit,Durban, South Africa

Background: Studies have demonstrated the association betweenBV and HIV acquisition in woman. The prevalence of BV re-ported in clinical trials conducted by the Medical ResearchCouncil HIV Prevention Research Unit (MRC HPRU) is between5–9%. In an attempt to reduce turnaround time for results, enabledirect contact with research clinics, facilitate staff capacitationand reduce costs, the HPRU was selected by the Protocol Re-ference Laboratory to perform in-house testing for diagnosingBV. We report here on the operational challenges associated withthe set-up of the laboratory to perform the analysis.

A220